A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

NCT06704685 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

ST-segment Elevation Myocardial Infarction (STEMI)

Interventions

DRUG: Butylphthalide
DRUG: Butylphthalide placebo

Sponsor

Xiangya Hospital of Central South University

Collaborators

[object Object]